Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Streptococcus pneumoniae is a common cause of respiratory tract infections.
• Antimicrobial resistance in S. pneumoniae complicates treatment globally and in the United States.
• Resistance has significantly evolved since the 1990s.

Purpose of the Study:

• To summarize the current state of antimicrobial resistance in Streptococcus pneumoniae.
• To highlight the challenges posed by multidrug-resistant strains.
• To propose strategies for controlling antimicrobial resistance.

Main Methods:

• Review of existing literature on Streptococcus pneumoniae antimicrobial resistance patterns.
• Analysis of resistance trends in the United States and worldwide.
• Identification of antimicrobial classes with high resistance rates.

Main Results:

• High rates of resistance observed for beta-lactams, macrolides, tetracyclines, chloramphenicol, and trimethoprim/sulfamethoxazole.
• Increasing prevalence of multidrug-resistant strains.
• Fluoro-quinolone resistance remains low in the United States.

Conclusions:

• Judicious antimicrobial use and new drug development are essential.
• Disease prevention strategies are critical.
• Understanding resistance mechanisms and pharmacodynamics is key to effective treatment development.